Nandish Vyas
Senior Partner
MumbaiPractice Area
Sectors
I enjoy the process of working on transactions, translating commercial requirements into a legal framework and adopting a resolution–based approach to negotiations. I am passionate about legal research and find joy in training younger colleagues.
Nandish is well placed to advise leading international funds on private equity and venture capital transactions in a range of sectors, including technology and healthcare. A client comments that they “have comfort with Nandish and rely on his advice and pragmatism.” Another market source describes him as an “excellent lawyer.”
Chambers & Partners Asia–Pacific (2022)Nandish Vyas has close to two decades of experience in corporate, private equity acquisitions, mergers, and restructuring transactions. He has assisted regulators in framing rules for corporate and competition laws and is recognised for his work by leading publications and journals. Prior to focusing on corporate transactions, he was a Research Assistant for India’s leading income–tax commentary and a commercial litigation lawyer.
DIRECTORSHIPS, MEMBERSHIPS AND AFFILIATIONS
- Invitee, Ministry of Corporate Affairs for drafting of rules relating to Merger & Amalgamations under the Companies Act, 2013 (2016)
- Invitee, Ministry of Corporate Affairs for drafting of rules relating to Merger Control under the Competition Act, 2002 (2011)
WORK HIGHLIGHTS
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
-
On a strategic venture for the sale and distribution of vaccines
-
On the sale of a majority stake to a private equity fund
-
On investments across insurance, healthcare and retail companies
-
On its investment in Indian e–commerce companies
-
On several investments in technology, healthcare, and e–commerce companies
RECENT RECOGNITION
2024
2023
2022
2021
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Legal Era
Named a Leading Lawyer for Private Equity
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Antitrust/Competition, Corporate/M&A and Private Equity & Investment Funds
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
BW Legal
Named among the ‘Top 40 under 40 – Elite Group of Lawyers & Legal Influencers’
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Antitrust/Competition, Corporate/M&A and Private Equity & Investment Funds
RECENT RECOGNITION
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Legal Era
Named a Leading Lawyer for Private Equity
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Antitrust/Competition, Corporate/M&A and Private Equity & Investment Funds
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
BW Legal
Named among the ‘Top 40 under 40 – Elite Group of Lawyers & Legal Influencers’
Chambers & Partners Asia–Pacific
Ranked for M&A and Private Equity
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Antitrust/Competition, Corporate/M&A and Private Equity & Investment Funds